세계의 의약품-의료기기 조합 제품 시장 조사 보고서 : 산업 분석, 규모, 점유율, 성장, 동향 예측(2024-2032년)
Global Drug Device Combination Products Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
상품코드:1498686
리서치사:Value Market Research
발행일:2024년 06월
페이지 정보:영문 175 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 의약품-의료기기 조합 제품 시장 규모는 2023년의 1,446억 6,000만 달러에서 2032년에는 2,967억 4,000만 달러 가까이에 이르고, 조사 기간 2024-2032년 CAGR은 8.31%로 추정 됩니다.
의약품-의료기기 조합제품은 약물·생물학적 제제와 의료기기의 조합, 치료효과를 가져오거나 특정한 치료기능을 실행하는 의료제품입니다. 이 제품들은 표적화된 약물 전달의 제공, 약효 증진, 환자의 컴플라이언스 개선, 또는 기존의 약물 제제 및 의료기기만으로는 달성할 수 없는 새로운 치료법의 실현 등을 목적으로 설계되어 있다 합니다. 이러한 제품에는 약물 용출 스텐트, 인슐린 펌프, 피임용 임플란트, 흡입 장비 등 다양한 의료 개입이 포함됩니다. 이러한 혁신적인 제품은 정밀의료, 개인화 치료 및 환자 편의성에 잠재적인 이점을 제공하여 다양한 치료 분야에서 치료 진보와 환자 결과 개선을 촉진합니다.
시장 역학
맞춤형 의료 및 표적 요법에 대한 수요 증가는 정확한 약물 전달 메커니즘과 환자 컴플라이언스 향상을 제공하는 혁신적인 의약품 및 의료기기 조합 제품의 개발을 뒷받침하고 있습니다. 의료 종사자와 환자가 보다 효과적이고 편리한 치료법을 요구하는 가운데, 의약품의 치료 이점과 의료기기의 정확성과 신뢰성을 결합한 제품에 대한 관심이 높아지고 있습니다. 또한 약물 제제 기술과 장비 설계의 진보로 만성 질환에서 급성 질환에 이르기까지 수많은 병리학에 대응하는 새로운 조합 제품의 개발이 가능해지고 있습니다. 또한 FDA의 Combination Product Policy와 EU의 MED(Medical Device Regulation) 등 제제에 관한 규제의 노력이나 가이드라인은 제조업체가 복잡한 규제 상황을 극복하고 혁신적인 제품을 시장에 투입하기 위한 틀을 제공합니다.
또한 제약기업, 의료기기 제조업체, 연구기관의 전략적 제휴는 기술 혁신과 의약품-의료기기 조합 제품 시장 개척을 촉진하고, 치료 영역에 걸친 새로운 의약품-의료기기 조합 제품의 개발을 촉진하고 있다 합니다. 의료비의 증대와 배합제에 대한 상환 지원이 연구 개발에 대한 투자를 촉진해, 의약품-의료기기 조합 제품 시장의 성장을 한층 더 촉진합니다. 그러나 배합제 개발과 관련된 규제상의 장애물과 복잡성, 상환에 관한 과제는 향후 몇 년간의 의약품-의료기기 조합 제품 시장의 성장에 영향을 줄 수 있습니다.
조사 보고서는 Porter's Five Force 모델, 시장 매력 분석 및 밸류체인 분석을 다룹니다. 이러한 도구는 업계의 구조를 명확하게 파악하고 세계 수준에서 경쟁의 매력을 평가하는 데 도움이 됩니다. 또한 이러한 도구는 의약품/의료 장비 조합 제품 세계 시장에서 각 부문을 종합적으로 평가할 수 있습니다. 의약품/의료기기 조합 제품 산업의 성장과 동향은 이 조사에 전반적인 접근을 제공합니다.
시장 세분화
이 섹션에서는 국가별 및 지역별 부문에 대한 자세한 데이터를 제공함으로써 전략 담당자가 각 제품 또는 서비스의 타겟 계층을 파악하고 향후 비즈니스 기회에 도움을 줄 수 있습니다.
지역별 분석
이 섹션에서는 북미, 유럽, 아시아태평양, 라틴아메리카, 중동 및 아프리카의 지역 전망을 다루며 의약품 및 의료기기 조합 제품 시장의 현재 및 미래 수요를 밝힙니다. 또한 모든 주요 지역에서 개별 용도 부문 수요, 추정 및 예측에 초점을 맞추었습니다.
요청이 있으시면 저희에게 연락하십시오. 당사의 설문조사팀은 고객의 요구에 따라 맞춤형 보고서를 제공할 수 있습니다.
The global demand for Drug Device Combination Products Market is presumed to reach the market size of nearly USD 296.74 Billion by 2032 from USD 144.66 Billion in 2023 with a CAGR of 8.31% under the study period 2024-2032.
Drug device combination products are medical products that combine a drug or biologic substance with a medical device to deliver therapeutic benefits or perform specific treatment functions. These products are designed to provide targeted drug delivery, enhance drug efficacy, improve patient compliance, or enable novel treatment modalities that may not be achievable with conventional drug formulations or medical devices alone. These products encompass various healthcare interventions, including drug-eluting stents, insulin pumps, contraceptive implants, and inhalation devices. These innovative products offer potential advantages in precision medicine, personalized therapy, and patient convenience, driving advancements in medical treatment and improving patient outcomes across various therapeutic areas.
MARKET DYNAMICS
The rising demand for tailored medicine and targeted therapies drives the development of innovative drug-device combination products that offer precise drug delivery mechanisms and improved patient compliance. As healthcare providers and patients seek more effective and convenient treatment options, there's a rising interest in combination products that combine pharmaceuticals' therapeutic benefits with medical devices' precision and reliability. Additionally, drug formulation technologies and device design advancements enable the development of novel combination products for numerous medical conditions, ranging from chronic diseases to acute conditions. Moreover, regulatory initiatives and guidelines governing combination products, such as the FDA's Combination Product Policy and the EU's Medical Device Regulation (MDR), provide a framework for manufacturers to navigate the complex regulatory landscape and bring innovative products to market.
Furthermore, strategic collaborations between pharmaceutical companies, medical device manufacturers, and research institutions drive innovation and drug-device combination products market expansion, fostering the development of new drug-device combination products across therapeutic areas. Increasing healthcare expenditure and reimbursement support for combination products incentivize investment in research and development, further driving drug-device combination products market growth. However, regulatory hurdles and complexities associated with combination product development and reimbursement challenges may challenge the drug device combination products market growth in the coming years.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Drug Device Combination Products. The growth and trends of Drug Device Combination Products industry provide a holistic approach to this study.
MARKET SEGMENTATION
This section of the Drug Device Combination Products market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
Transdermal Delivery Systems (Active Transdermal Systems, Passive Transdermal Systems)
Orthopedic Combination Products (Bone Graft Implants, Antibiotic Loaded Bone Cement)
Antimicrobial Catheters (Urological Catheters, Cardiovascular Catheters, Other Catheters, Other Products)
By Application
Cardiovascular Disorders
Diabetes
Respiratory Problems
Cancer Treatment
Antimicrobial Application
Other
By End-use
Hospitals And Clinics
Ambulatory Surgical Centers
Home Care Settings
Other
REGIONAL ANALYSIS
This section covers the regional outlook, which accentuates current and future demand for the Drug Device Combination Products market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Drug Device Combination Products market include Abbott Laboratories, AbbVie Inc., Alcon Inc., Bausch Health Companies Inc, Baxter International Inc., Bayer AG, Becton, Dickinson And Company, Boston Scientific Corporation, GlaxoSmithKline Plc, Johnson & Johnson, Kaleo Inc., Medtronic Plc, Novartis AG, Sinomed, Smith & Nephew Plc, Teleflex Incorporated, Teva Pharmaceutical Industries Ltd. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
3. DRUG DEVICE COMBINATION PRODUCTS - INDUSTRY ANALYSIS
3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
3.7.1 Market Attractiveness Analysis By Product
3.7.2 Market Attractiveness Analysis By Application
3.7.3 Market Attractiveness Analysis By End-use
3.7.4 Market Attractiveness Analysis By Region
4. VALUE CHAIN ANALYSIS
4.1. Value Chain Analysis
4.2. Raw Material Analysis
4.2.1 List of Raw Materials
4.2.2 Raw Material Manufactures List
4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
4.4.1 Direct Marketing
4.4.2 Indirect Marketing
4.4.3 Marketing Channel Development Trend
5. GLOBAL DRUG DEVICE COMBINATION PRODUCTS MARKET ANALYSIS BY PRODUCT
5.1. Overview By Product
5.2. Historical and Forecast Data Analysis By Product
5.3. Drug-Eluting Stents (Coronary Drug-Elating Stents, Peripheral Drug-Eluting Stents) Historic and Forecast Sales By Regions
5.4. Infusion Pumps (Implantable Infusion Pumps, Insulin Infusion Pumps, Patient-Controlled Analgesia Pumps, Ambulatory Infusion Pumps, Volumetric Infusion Pumps, Disposable Infusion Pumps) Historic and Forecast Sales By Regions
5.5. Photodynamic Therapy Historic and Forecast Sales By Regions
5.6. Wound Care Combination Product Historic and Forecast Sales By Regions
5.7. Prefilled Syringes (Single-Chamber Prefilled Syringes, Dual-Chamber Prefilled Syringes, Customized Prefilled Syringes) Historic and Forecast Sales By Regions
5.8. Drug-Eluting Balloons (Coronary Drug-Eluting Balloons, Peripheral Drug-Eluting Balloons) Historic and Forecast Sales By Regions
5.9. Nebulizers Historic and Forecast Sales By Regions
5.10. Inhalers (Drug Powdered Inhalers (DPIs), Metered Dose Inhalers (MDIs), Soft Mist Inhalers (SMIs)) Historic and Forecast Sales By Regions
5.11. Transdermal Delivery Systems (Active Transdermal Systems, Passive Transdermal Systems) Historic and Forecast Sales By Regions
5.12. Orthopedic Combination Products (Bone Graft Implants, Antibiotic Loaded Bone Cement) Historic and Forecast Sales By Regions
5.13. Antimicrobial Catheters (Urological Catheters, Cardiovascular Catheters, Other Catheters, Other Products) Historic and Forecast Sales By Regions
6. GLOBAL DRUG DEVICE COMBINATION PRODUCTS MARKET ANALYSIS BY APPLICATION
6.1. Overview By Application
6.2. Historical and Forecast Data Analysis By Application
6.3. Cardiovascular Disorders Historic and Forecast Sales By Regions
6.4. Diabetes Historic and Forecast Sales By Regions
6.5. Respiratory Problems Historic and Forecast Sales By Regions
6.6. Cancer Treatment Historic and Forecast Sales By Regions
6.7. Antimicrobial Application Historic and Forecast Sales By Regions
6.8. Other Historic and Forecast Sales By Regions
7. GLOBAL DRUG DEVICE COMBINATION PRODUCTS MARKET ANALYSIS BY END-USE
7.1. Overview By End-use
7.2. Historical and Forecast Data Analysis By End-use
7.3. Hospitals And Clinics Historic and Forecast Sales By Regions
7.4. Ambulatory Surgical Centers Historic and Forecast Sales By Regions
7.5. Home Care Settings Historic and Forecast Sales By Regions
7.6. Other Historic and Forecast Sales By Regions
8. GLOBAL DRUG DEVICE COMBINATION PRODUCTS MARKET ANALYSIS BY GEOGRAPHY
8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
8.3.1 Overview, Historic and Forecast Data Sales Analysis
8.3.2 North America By Segment Sales Analysis
8.3.3 North America By Country Sales Analysis
8.3.4 United States Sales Analysis
8.3.5 Canada Sales Analysis
8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
8.4.1 Overview, Historic and Forecast Data Sales Analysis
8.4.2 Europe By Segment Sales Analysis
8.4.3 Europe By Country Sales Analysis
8.4.4 United Kingdom Sales Analysis
8.4.5 France Sales Analysis
8.4.6 Germany Sales Analysis
8.4.7 Italy Sales Analysis
8.4.8 Russia Sales Analysis
8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
8.5.1 Overview, Historic and Forecast Data Sales Analysis
8.5.2 Asia Pacific By Segment Sales Analysis
8.5.3 Asia Pacific By Country Sales Analysis
8.5.4 China Sales Analysis
8.5.5 India Sales Analysis
8.5.6 Japan Sales Analysis
8.5.7 South Korea Sales Analysis
8.5.8 Australia Sales Analysis
8.5.9 South East Asia Sales Analysis
8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
8.6.1 Overview, Historic and Forecast Data Sales Analysis
8.6.2 Latin America By Segment Sales Analysis
8.6.3 Latin America By Country Sales Analysis
8.6.4 Brazil Sales Analysis
8.6.5 Argentina Sales Analysis
8.6.6 Peru Sales Analysis
8.6.7 Chile Sales Analysis
8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
8.7.1 Overview, Historic and Forecast Data Sales Analysis
8.7.2 Middle East & Africa By Segment Sales Analysis
8.7.3 Middle East & Africa By Country Sales Analysis
8.7.4 Saudi Arabia Sales Analysis
8.7.5 UAE Sales Analysis
8.7.6 Israel Sales Analysis
8.7.7 South Africa Sales Analysis
8.7.8 Rest Of Middle East And Africa Sales Analysis
9. COMPETITIVE LANDSCAPE OF THE DRUG DEVICE COMBINATION PRODUCTS COMPANIES
9.1. Drug Device Combination Products Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments
10. COMPANY PROFILES OF DRUG DEVICE COMBINATION PRODUCTS INDUSTRY
10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Abbott Laboratories
10.3.1 Company Overview
10.3.2 Company Revenue
10.3.3 Products
10.3.4 Recent Developments
10.4. AbbVie Inc.
10.4.1 Company Overview
10.4.2 Company Revenue
10.4.3 Products
10.4.4 Recent Developments
10.5. Alcon Inc.
10.5.1 Company Overview
10.5.2 Company Revenue
10.5.3 Products
10.5.4 Recent Developments
10.6. Bausch Health Companies Inc
10.6.1 Company Overview
10.6.2 Company Revenue
10.6.3 Products
10.6.4 Recent Developments
10.7. Baxter International Inc.
10.7.1 Company Overview
10.7.2 Company Revenue
10.7.3 Products
10.7.4 Recent Developments
10.8. Bayer AG
10.8.1 Company Overview
10.8.2 Company Revenue
10.8.3 Products
10.8.4 Recent Developments
10.9. Becton, Dickinson And Company
10.9.1 Company Overview
10.9.2 Company Revenue
10.9.3 Products
10.9.4 Recent Developments
10.10. Teva Pharmaceutical Industries Ltd
10.10.1 Company Overview
10.10.2 Company Revenue
10.10.3 Products
10.10.4 Recent Developments
10.11. Boston Scientific Corporation
10.11.1 Company Overview
10.11.2 Company Revenue
10.11.3 Products
10.11.4 Recent Developments
10.12. GlaxoSmithKline Plc
10.12.1 Company Overview
10.12.2 Company Revenue
10.12.3 Products
10.12.4 Recent Developments
10.13. Johnson & Johnson
10.13.1 Company Overview
10.13.2 Company Revenue
10.13.3 Products
10.13.4 Recent Developments
10.14. Kaleo Inc.
10.14.1 Company Overview
10.14.2 Company Revenue
10.14.3 Products
10.14.4 Recent Developments
10.15. Medtronic Plc
10.15.1 Company Overview
10.15.2 Company Revenue
10.15.3 Products
10.15.4 Recent Developments
10.16. Novartis AG
10.16.1 Company Overview
10.16.2 Company Revenue
10.16.3 Products
10.16.4 Recent Developments
10.17. Sinomed
10.17.1 Company Overview
10.17.2 Company Revenue
10.17.3 Products
10.17.4 Recent Developments
10.18. Smith & Nephew Plc
10.18.1 Company Overview
10.18.2 Company Revenue
10.18.3 Products
10.18.4 Recent Developments
10.19. Teleflex Incorporated
10.19.1 Company Overview
10.19.2 Company Revenue
10.19.3 Products
10.19.4 Recent Developments
Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies
